This federal contract award, valued at $3,826.50, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00. This delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a completion date of December 13, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. As a key supplier to the Department of Defense, Dakota Drug, Inc. provides a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.
Generated 3/16/25, 12:53 AM